MVision AI

MVision AI GBS™ (Guideline Based Segmentation) solution for Radiotherapy powered by AI.

It’s Day 2 at AAPM 2025.Thanks to everyone who has stopped by Booth  #7007 to talk AI, clinical alignment, and the futur...
28/07/2025

It’s Day 2 at AAPM 2025.

Thanks to everyone who has stopped by Booth #7007 to talk AI, clinical alignment, and the future of medical physics. The energy and conversations have been fantastic.

Today, we are back at the booth, ready to continue the conversation. Whether you're exploring new approaches to auto-contouring or curious how our tools can support your clinical workflow, we’d love to connect.

Washington, DC, we’re on our way.MVision AI will be at AAPM 2025 from July 27 to 30. Visit us at Booth  #7007 to catch u...
22/07/2025

Washington, DC, we’re on our way.

MVision AI will be at AAPM 2025 from July 27 to 30. Visit us at Booth #7007 to catch up with the team and see what’s new.

This year’s theme, “Coming Together to Forge Ahead in Medical Physics,” resonates deeply with our mission. Collaboration across disciplines like AI, imaging, and radiation therapy isn’t just an ideal — it’s the foundation for how we build tools that support smarter, more unified care in oncology.

On site will be Mahmudul Hasan, Founder and Executive Director; Gregory Bolard, Chief Scientific Officer; and Martin Clay, VP of Sales US. We’ll be sharing how our AI-powered solutions are helping clinical teams strengthen alignment, reduce variation, and move forward together.

Let’s talk about what collaboration in cancer care can really look like.

🚀 Want to help shape the future of cancer care?MVision AI is looking for a Clinical Success Specialist to support the re...
18/06/2025

🚀 Want to help shape the future of cancer care?

MVision AI is looking for a Clinical Success Specialist to support the real-world implementation of our AI-powered solutions in radiotherapy clinics worldwide.

This role is hands-on, collaborative, and purpose-driven — ideal for someone with a clinical background who’s ready to bridge patient care and cutting-edge technology.

📍 Learn more and apply here: https://eu1.hubs.ly/H0l0t130

MVision AI has named Gregory Bolard as its new Chief Scientific Officer, marking an important step forward in our work t...
17/06/2025

MVision AI has named Gregory Bolard as its new Chief Scientific Officer, marking an important step forward in our work to shape clinically driven AI in radiotherapy.

With a background in engineering and medical physics, and more than 15 years of clinical leadership experience across Europe, Gregory brings deep expertise and a strong understanding of the daily realities oncology teams face around the world.

We sat down with Gregory to talk about his journey to MVision AI, his vision for the future of cancer care, and how AI can best support clinical decision-making. Topics ranged from the importance of transparency and safety in clinical AI, to how AI can help democratize access to high-quality treatment and transform complex workflows into integrated, intelligent systems.

Read the full conversation here: https://eu1.hubs.ly/H0l1Gm20

With Gregory as CSO, we’re strengthening our focus on clinically grounded innovation.

MVision AI is heading to Las Vegas for the 50th Annual AAMD Meeting, June 15–18.We’ll be showcasing our Guideline-Based ...
11/06/2025

MVision AI is heading to Las Vegas for the 50th Annual AAMD Meeting, June 15–18.

We’ll be showcasing our Guideline-Based Segmentation (GBS™) suite, built to help radiation oncology professionals meet the rising demands of precision, speed, and consistency in treatment planning.

Stop by Booth #120 to explore the technology and have a chat with MVisionaries Mahmudul Hasan and Martin Clay.

The GBS™ suite includes Contour+, Guide, and Verify. These solutions support auto-contouring, contour evaluation, and clinical guideline training. Together, they help reduce manual workload, improve contour consistency, and promote alignment with clinical standards in cancer care.

We’re looking forward to meaningful conversations about the present and future of dosimetry.

There’s still time to register for our Dose+ webinar tomorrow.Get a closer look at Dose+, MVision AI’s solution for AI-g...
04/06/2025

There’s still time to register for our Dose+ webinar tomorrow.

Get a closer look at Dose+, MVision AI’s solution for AI-guided plan optimisation in radiotherapy. Discover how personalised dose prediction can support more consistent treatment planning.

Rachel Buckingham, Clinical Success Specialist, will explore key features and highlight the clinical value during the live session.

Date & Time: June 5, 16:00–17:00 (Helsinki time)
Register here: https://bit.ly/452HvTP

Make sure you’re part of the conversation shaping the future of radiotherapy planning.

Spring is (technically) here at our home office in Helsinki 🌱Yesterday, we gave our usual Wednesday afternoon coffee a s...
29/05/2025

Spring is (technically) here at our home office in Helsinki 🌱

Yesterday, we gave our usual Wednesday afternoon coffee a seasonal twist — the grill made its first appearance of the year out on the terrace! 🍢

While the weather kept most of us indoors, it didn’t stop us from enjoying good food and a nice midweek break.

(ish)

Join us on June 5 at 16:00 (Helsinki time) for a live webinar introducing Dose+, MVision AI’s personalised dose predicti...
28/05/2025

Join us on June 5 at 16:00 (Helsinki time) for a live webinar introducing Dose+, MVision AI’s personalised dose prediction tool for radiotherapy planning.

🎙️ Featuring: Rachel Buckingham, Clinical Success Specialist
🗓️ Date & Time: June 5, 16:00–17:00 EEST (UTC+03:00)
🔗 Register now: https://eu1.hubs.ly/H0kv8-v0

Don’t miss this opportunity to see Dose+ in action!

hashtag hashtag hashtag hashtag

This week is the European Week Against Cancer (May 25–31), a time to recognize the importance of prevention, early detec...
26/05/2025

This week is the European Week Against Cancer (May 25–31), a time to recognize the importance of prevention, early detection, and access to care. At MVision AI, we’re proud to support clinicians with solutions that help improve the consistency and quality of radiotherapy planning. Our focus remains on helping professionals deliver care the best possible outcomes for their patients.

23/05/2025

We’ve just released a short video that introduces Dose+, our AI-powered dose prediction solution.

The video gives you a look at the thinking behind Dose+ and how it supports treatment planning in radiation oncology.

If you’ve been following our updates, this will help bring everything into clearer focus.

ESTRO25 is wrapping up — and what a week it’s been.A heartfelt thanks to everyone who visited our booth, asked questions...
06/05/2025

ESTRO25 is wrapping up — and what a week it’s been.

A heartfelt thanks to everyone who visited our booth, asked questions, booked demos, watched our live Dose+ presentations, and shared their perspectives.

From thoughtful conversations to inspiring exchanges, it’s been a reminder of why we do what we do: to support clinicians in delivering better care, powered by smarter tools like GBS ™ and Dose+.

It’s been a privilege to connect with so many dedicated professionals.

Next stop: .

It’s Day 3 at  , and there’s still plenty happening at the MVision AI booth.If you haven’t had a chance to stop by yet, ...
04/05/2025

It’s Day 3 at , and there’s still plenty happening at the MVision AI booth.

If you haven’t had a chance to stop by yet, now’s the perfect time. Our final live Dose+ presentation starts at 16:30 at Booth #185.

Discover how our AI-powered dose prediction software supports faster, more consistent radiotherapy planning and how it could fit into your clinic’s workflow.

You can also still book a demo to explore Dose+, Contour+, Guide, or Verify:
👉 https://bit.ly/438WlFU

Or just come by Booth 185 for a conversation with the team. We’re always glad to exchange ideas and hear about your work too.

Osoite

PaciuksenKatu 29
Helsinki
00270

Hälytykset

Tiedä ensimmäisenä ja anna meille oikeus lähettää sinulle sähköpostitse uutisia ja promootioita MVision AI :ltä. Sähköpostiosoitettasi ei käytetä muihin tarkoituksiin, ja voit perua milloin tahansa.

Jaa

Kategoria